ArticleHereditary cancer in clinical practice2012

Chemokine Ligand 5 (CCL5) and chemokine receptor (CCR5) genetic variants and prostate cancer risk among men of African Descent: a case-control study.

Lacreis R Kidd et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.